Mitogen-activated protein kinase (MAPK) is activated in cytoplasm in response to extracellular signals and then is translocated to nucleus. A directed activator for MAPK, MAPK kinase (MAPKK), stays in cytoplasm to transmit the signal from the plasma membrane to MAPK. Here we show that MAPKK contains a short amino acid sequence in the N-terminal region (residues 32-44), which acts as a nuclear export signal (NES) and thus is required for cytoplasmic localization of MAPKK. This NES sequence of MAPKK, like that of protein kinase inhibitor of cAMP-dependent protein kinase or Rev, is rich in leucine residues, which are crucial for the NES activity. Furthermore, the NES peptide of protein kinase inhibitor, as well as the NES peptide of MAPKK, inhibited the nuclear export of ovalbumin conjugated to the NES peptide of MAPKK. These results may suggest a common mechanism of nuclear export using a general leucine-rich NES.
1 is activated in response to a wide variety of extracellular stimuli (1) (2) (3) (4) and functions as one of several important mediators of signal transductions that control cell proliferation (5-10), cell differentiation (7, 11, 12) , and early embryonic development (13) (14) (15) . Activation of MAPK requires its dual phosphorylation on threonine and tyrosine residues catalyzed by MAPK kinase (MAPKK), a dual-specificity protein kinase (16, 17) . MAPKK exists in cytoplasm (18 -20) and is activated by serine phosphorylation (21) (22) (23) catalyzed by an upstream serine/threonine kinase, such as Raf-1 (24 -26) , which may be activated near the plasma membrane (27) (28) (29) (30) . Thus, MAPKK is a key intermediate in the MAPK cascade, and cytoplasmic localization of MAPKK may be important for the proper signal transduction of the MAPK cascade. In fact, MAPK is first activated in cytoplasm through activation of MAPKK and then translocated to the nucleus (18, 31, 32) . However, it remains unclear how cytoplasmic localization of MAPKK is achieved.
The first identification of nuclear export signal (NES) (33) (34) (35) (36) (37) (38) was recently done in studies characterizing two specific proteins (human immunodeficiency virus, type I-coded Rev protein and inhibitor (PKI) of cAMP-dependent protein kinase) that rapidly shuttle between the nucleus and the cytoplasm. The NES sequences in Rev and PKI are both rich in hydrophobic residues, in which three leucine residues are critical for nuclear export activity (33) (34) (35) (36) (37) (38) .
During the course of experiments originally designed to elucidate the mechanism of the nuclear translocation of MAPK, we found that MAPKK has in its N-terminal region a short sequence that regulates its subcellular distribution and that the sequence has an NES activity. This NES sequence of MAPKK, like the NES of PKI or Rev, is rich in leucine residues, which were found to be crucial for its NES activity. Furthermore, the NES of PKI and the NES of MAPKK competed with each other. These results may suggest a common mechanism of nuclear export using a general leucine-rich NES.
MATERIALS AND METHODS
DNA Constructs-An EcoRI fragment of Xenopus MAPKK cDNA was subcloned into M13 mp18 (13) . The mutagenesis of Leu-33 to Ala and Leu-37 to Ala in Xenopus MAPKK was performed by method of Kunkel et al. (43) using mutagenic primer 5Ј-AGACAAACCTTGAAGCTGCG-CAGAAAAAGGCGGAAGAGCTTGAGCTGGA-3Ј to yield L33A/L37A-MAPKK. To yield L40A/L42A-MAPKK, mutagenic primer 5Ј-AGA-AAAAGTTGGAAGAGGCTGAGGCGGATGAGCAGCAGAGGAA-3Ј was used. The open reading frame of L33A/L37A-MAPKK or L40A/ L42A-MAPKK was amplified by PCR with a 5Ј primer, 5Ј-CACTAGAT-CTCAACATGCCTAAAAAGAA-3Ј, and a 3Ј primer, 5Ј-GCCAAGATC-TCTCACACTCCGGCGGCAT-3Ј, which produce BglII sites at both ends of the mutants of MAPKK. Each BglII fragment was cloned into pcDL-SR␣457. Wild-type (WT)-MAPKK, SESE-MAPKK (13), or ⌬-SE-SE-MAPKK (9, 42) was inserted into expression vector pcDL-SR␣457, which is under the control of an SR␣ promoter. The N-terminal region (residues 1-67) of Xenopus MAPKK was amplified by PCR with a 5Ј primer, 5Ј-ACTAGATATCAACATGCCTAAAAAGAAG-3Ј, which produces an EcoRV site at N-terminal end of MAPKK, and a 3Ј primer, 5Ј-GCGCGAATTCGTCGTCATCCTTCAGTTC-3Ј, which produces a EcoRI site at the end of MAPKK. An EcoRV-EcoRI fragment was cloned into pGEX-2T.
Preparation of Proteins-GST-MAPKK (residues 1-67) was bacterially expressed and purified on glutathione-agarose as described previously (23) . BSA (Sigma) dissolved in 0.1 M Na 2 CO 3 , pH 9.0 (final concentration, 2 mg/ml), was mixed with tetramethyl rhodamine isothiocianate (RITC; final concentration, 0.3 mg/ml) dissolved in dimethyl sulfoxide at 4°C for 15 h. Labeled BSA was purified by Sephadex G100 gel filtration chromatography equilibrated in 0.1 M Na 2 CO 3 , pH 8.0, and then dialyzed against 10 mM HEPES, pH 7.4, 120 mM KCl.
Cell Cultures and Microinjection-Rat fibroblastic 3Y1 cells were plated onto CELLocate coverslips (Eppendorf, Inc.) and cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum and antibiotics (100 units/ml penicillin and 0.2 mg/ml kanamycine) for 2 days. Microinjection was performed using an IM-188 apparatus (Narishige). The samples in injection buffer (10 mM HEPES-KOH, pH 7.4, 120 mM KCl) were injected into the cell nuclei or the cytoplasm of cells cultured on CELLocate coverslips. * This work was supported by grants-in-aid from the Ministry of Education, Science and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed. Fax: 81-75-751-3992. 1 The abbreviations used are: MAPK, mitogen-activated protein kinase; MAPKK, MAP kinase kinase; PKI, protein kinase inhibitor; NES, nuclear export signal; WT, wild type; GST, glutathione S-transferase; BSA, bovine serum albumin; RITC, tetramethyl rhodamine isothiocyanate; PBS, phosphate-buffered saline; OV, ovalbumin; L-OV, L peptideconjugated OV; A-OV, A peptide-conjugated OV; SESE, S218E/S222E; ⌬-SESE, ⌬(residues 32-51)SESE; SMCC, succinimidyl 4-(N-maleimidomethyl)cylohexane-1-carboxylate.
Cell Staining-After injection, the cells were fixed with 3.7% formaldehyde in phosphate-buffered saline (PBS) for 30 min at room temperature and then permeabilized with 0.5% Triton X-100 in PBS for 10 min. After blocking with 3% skim milk in PBS, the coverslips were incubated with primary antibodies at room temperature for 1 h and then with fluorescein isothiocyanate-conjugated goat antibody to rabbit IgG (Cappel) or fluorescein isothiocyanate-conjugated goat antibody to mouse IgG (Amersham). The primary antibodies and dilution used here were a rabbit antipeptide antibody raised against the N-terminal residues 1-16 of Xenopus MAPKK (1:100 dilution), a mouse monoclonal antibody to Xenopus MAPKK (4A5) (1:100 dilution), and a rabbit antiovalbumin antibody (40 g/ml) (Cappel).
Conjugation of Synthetic Peptides to Ovalbumin-A peptide (L peptide) corresponding to the sequence of residues 32-44 of Xenopus MAPKK (residues 32-44) (CALQKKLEELELDE) and its mutant peptide (A peptide) (CAAQKKAEEAEADE) in which all leucines were replaced by alanines were synthesized. These synthetic peptides were conjugated to ovalbumin (OV) with a bifunctional cross-linking reagent sulfo-SMCC (Calbiochem). Briefly, sulfo-SMCC-activated OV was prepared by incubating OV (5 mg/ml) and sulfo-SMCC (8 mg/ml) in PBS (100 mM NaH 2 PO 4 , pH 8.0, 150 mM NaCl) at 20°C for 1 h. Excess cross-linker was removed by a prepacked gel filtration column, BioGel-10 DG (Bio-Rad), in PBS (pH 7.0). The L peptide (3 mg/ml) or the A peptide (3 mg/ml) was added to the sulfo-SMCC-activated OV (ϳ2 mg/ml). After incubation for 3 h at room temperature, free peptide was removed by a prepacked gel filtration column, Bio-Gel-10 DG (Bio-Rad), equilibrated in PBS (pH 7.0). The L peptide-conjugated OV (L-OV) or the A peptide-conjugated OV (A-OV) was concentrated by Centricon 30 (Amicon, Inc.). The coupling ratios of both conjugations were ϳ10 -15 peptides/OV molecule because the L-OV and the A-OV had an apparent molecular mass of ϳ65 kDa as estimated by SDS-polyacrylamide gel electrophoresis (data not shown).
RESULTS AND DISCUSSION
To generate constitutively active forms of MAPKK that show varying degrees of the activity, we made a number of mutant forms of Xenopus MAPKK according to previously described methods (7, 9, 21-23); SESE-MAPKK was made by combined replacement of serine 218 and 222 by glutamic acid (7, (21) (22) (23) , ⌬-WT-MAPKK by deletion of N-terminal residues 32-51 (9), and ⌬-SESE-MAPKK by the combination of both methods (9) . A plasmid harboring each of these mutants or wild-type MAPKK was injected into the nuclei of rat 3Y1 cells, and subcellular localization of the expressed MAPKK was determined by the cell-staining method 6 h after injection. WT-MAPKK and SESE-MAPKK were excluded from the nucleus and located in the cytoplasm, whereas ⌬-WT-MAPKK and ⌬-SESE-MAPKK were present in both the nucleus and the cytoplasm (Fig. 1A) . The observed difference in their subcellular distribution seemed to result from the N-terminal deletion in the mutants of ⌬-WT-MAPKK and ⌬-SESE-MAPKK. Because the exclusion of WT-MAPKK and SESE-MAPKK from the nucleus was so complete in spite of the relatively small size of the molecule (ϳ45 kDa), which could enter the nucleus by diffusion, we hypothesized that MAPKK might have a cytoplasmic retention signal or a nuclear export signal in the N-terminal region. To test this, we made a fusion protein between GST and the N-terminal region (residues 1-67) of MAPKK (GST-MAPKK (residues 1-67)) and injected it together with tetramethyl rhodamine isothiocianate-labeled bovine serum albumin (RITC-BSA) into the nucleus or the cytoplasm of 3Y1 cells. When injected into the nucleus, GST-MAPKK (1-67) was excluded almost completely from the nucleus within 1 h, whereas RITC-BSA remained in the nucleus (Fig. 1B, Nu. ). When injected into the cytoplasm, both proteins stayed in the cytoplasm, excluded from the nucleus (Fig. 1B, Cyt.) . These results may suggest that the N-terminal region (residues 1-67) of MAPKK can work as an NES. As the deletion of the N-terminal residues 32-51 of MAPKK inhibited the MAPKK molecule from being excluded from the nucleus (Fig. 1A) , the NES activity may reside in residues 32-51 ( Fig. 2A) .
By looking at the amino acid sequence of residues 32-51, we have found that the sequence of residues 32-42 is rich in leucine (Leu . Cells were stained with antipeptide antibody raised against the N-terminal residues 1-16 of Xenopus MAPKK at 6 h after injection. The fields were visualized and photographed with a Zeiss AXIOPHOT microscope. B, the N-terminal region of Xenopus MAPKK (residues 1-67) was fused to GST (GST-K (1-67) ). The fusion protein (GST-KK(1-67)) was bacterially expressed and purified on glutathione-agarose. GST-KK(1-67) was injected with RITC-BSA into the nucleus (Nu.) or the cytoplasm (Cyt.) of 3Y1 cells. Cells were fixed at 1 h after injection and then stained as above. All cells in the field were injected. There is variability in the total intensity of staining in the field because of the variability in amounts injected.
FIG. 2. A leucine-rich NES sequence of MAPKK.
A, the amino acid sequence of the deleted region (residues 32-51) in ⌬WT-MAPKK. B, comparison of the NES sequences of MAPKK, PKI␣, and Rev. Conservative hydrophobic residues (leucine and isoleucine) in the NES sequence are boxed.
tablished NES sequence (residues 33-38) in PKI of cAMP-dependent protein kinase and Rev (Fig. 2B) ; the positions of four leucine residues in the sequence of residues 33-42 of MAPKK may correspond to those of three leucine residues and an isoleucine residue in the NES of PKI (boxed in Fig. 2B) . A recent study (38) has shown that the NES of PKI is powerful and autonomous enough to trigger nuclear export when chemically conjugated to the transport substrate. To test whether the leucine-rich sequence in MAPKK can act as an autonomous NES, the peptide corresponding to residues 32-44 of MAPKK (the L peptide) was synthesized and chemically conjugated to ovalbumin (OV) through an additional N-terminal cysteine of the peptide. The resultant L-OV had an apparent molecular mass of ϳ65 kDa and was estimated to have ϳ10 -15 L peptides/OV molecule. When injected into the nucleus, L-OV was found in the cytoplasm (Fig. 3A, upper) and was excluded from the nucleus almost completely within 15 min (Figs. 3A, upper,  and 4, upper) . In contrast, co-injected RITC-BSA remained in the nucleus (Fig. 3A, upper) . When injected into the cytoplasm, both proteins remained in the cytoplasm (data not shown). The nuclear export of L-OV was sensitive to low temperatures; at 0°C, L-OV remained in the nucleus as long as 1 h after nuclear injection (Fig. 3B) . In contrast, a small molecule such as fluorescein isothiocyanate (molecular weight, 389.4) could diffuse out of the nucleus even at 0°C, although the rate was slowed down by lowering the temperature; therefore, the passive diffusion may not be prevented completely by lowering the temperature. Therefore, it is likely that the nuclear export of L-OV may be an active process. The leucines in the NES of PKI were shown to be important for the NES activity (38) . Then, the mutant peptide in which all the four leucines (Leu 33 , Leu 37 , Leu 40 , and Leu 42 of MAPKK) were replaced by alanines (the A peptide) was synthesized and conjugated to OV. The resultant A-OV also had an apparent molecular mass of ϳ65 kDa. When injected into the nucleus, the mutant peptide-conjugated OV (A-OV) was incapable of crossing the nuclear envelope and remained in the nucleus (Fig. 3A, lower) . These results, taken together, indicate that the N-terminal sequence of residues 32-44 (L peptide) of MAPKK is a specific and strong NES and that the leucines in the sequence are crucial.
To further show that the NES of MAPKK (L peptide) is self-sufficient, we examined whether or not free L peptide could inhibit the nuclear export of L-OV. When L-OV was injected into the nucleus together with an excess amount of free L peptide, the export of L-OV from the nucleus was almost completely inhibited (Fig. 4, L-OV ϩ KK-L peptide) . In contrast, the same amount of free A peptide (in which leucines were replaced by alanines) did not inhibit the nuclear export of L-OV at all (Fig. 4, L-OV ϩ KK-A peptide) . This result may indicate that the L peptide-mediated export is a saturable process and may suggest the existence of an L peptide (NES) binding protein (i.e. an NES receptor) as a limiting factor for the nuclear export of L-OV.
The results presented so far have shown that the short amino acid sequence (residues 32-44) in the N-terminal region of MAPKK can act as an autonomous, strong NES. The identification of NES as a short amino acid sequence sufficient for rapid nuclear export of proteins first came from the recent, detailed analyses (33-38) of the nuclear trafficking pathways of two shuttling proteins, PKI of cAMP-dependent protein kinase and Rev. The NES in PKI of cAMP-dependent protein kinase was defined as a leucine-rich sequence, and the similar sequence in Rev was also identified as an NES (33-38) . The present analysis of a cytoplasmic protein, MAPKK, identified another example of an NES, the sequence of which is similar to that of both other NESs in terms of the positions of a number of hydrophobic residues (leucines and isoleucine, Fig. 2B,  boxed) , although other parts show little or no similarity. Then, to test the possibility that the NES of MAPKK and the NES of PKI use similar mechanisms, the NES peptide of PKI (PKI-L peptide) and its mutant peptide, in which leucines and isoleucine were replaced by alanines (PKI-A peptide), were synthesized and examined for their ability to inhibit the nuclear export of the NES of MAPKK-conjugated OV (L-OV). The PKI-L peptide, like MAPKK-L peptide, inhibited the nuclear export of L-OV when co-injected into the nucleus (Fig. 4 , L-OV ϩ PKI-L peptide), whereas the PKI-A peptide did not (Fig. 4 , L-OV ϩ PKI-A peptide). This suggests that the NES of PKI competes with the NES of MAPKK for a common limiting factor(s), presumably the same or a similar NES receptor, and that a leucine-rich NES may be representative of a general signal for nuclear export. It remains to be examined, however, whether or not the NES of Rev competes with the NES of PKI or MAPKK.
To confirm the importance of the NES of MAPKK in its subcellular distribution, alanine substitution mutations were made in the NES portion of MAPKK. Two mutant MAPKKs of double mutation were produced: L33A/L37A-KK and L40A/ L42A-MAPKK. A plasmid harboring each mutant MAPKK was injected into the nuclei, and 6 h after injection the subcellular distribution was determined. Whereas wild-type MAPKK was localized exclusively in the cytoplasm (Fig. 5, WT-KK) , both of mutant MAPKKs were distributed evenly throughout the cell, present in both the nucleus and the cytoplasm (Fig. 5 , L33A/ L37A-KK and L40A/L42A-KK). These results may be interpreted as suggesting that MAPKK could cross the nuclear envelope to the nucleus by diffusion if it did not have NES and that the NES of MAPKK may thus define the cytoplasmic localization of MAPKK. Furthermore, the data shown in Fig. 5 support the importance of the four leucine residues in the NES of MAPKK. This NES sequence is conserved in mammalian (MAPKK1 (MEK1) and MAPKK2 (MEK2)) and Xenopus MAPKK. Thus, the NES of MAPKK would be used to ensure permanent cytoplasmic localization of MAPKK. The cytoplasmic localization of molecules in general was thought to be ensured by increasing their molecular size beyond the limit for passive diffusion through the nuclear envelope pore, by their having a domain responsible for cytoplasmic retention, such as binding to other cytoplasmic components, or simply by their not having a nuclear localization signal. In the case of MAPKK, however, its cytoplasmic localization may be determined by its NES. As MAPKK must receive the signal from MAPKK kinase (such as Raf-1) in the cytoplasm, the existence of this mechanism for ensuring cytoplasmic localization of MAPKK by an active process would be reasonable. The cytoplasmic localization of MAPKK would be important, as mentioned above, for the proper, regulated signal transduction from the receptor in the plasma membrane to the activation of MAPK in the cytoplasm. The biological significance of the NES of MAPKK, however, should be elucidated in more detail in future studies.
The finding of a leucine-rich NES in MAPKK and the demonstration of competition between the NES of MAPKK and the NES of PKI might suggest a concept of a general leucine-rich NES. The N-terminal region (residues 32-51) of MAPKK containing the NES portion is thought to form an ␣-helical folding because this portion is predominantly hydrophilic and encompasses favorable residues to stabilize ␣-helical conformation (9, 40, 41) . The NES of PKI was also suggested to form an ␣-helix (38) . A comparison of the structure of both NESs by the helical wheel representation revealed the same feature: an ␣-helix with three leucine residues (Leu (38)) are crucial for the NES. Therefore, it is interesting to speculate that a presumable NES receptor recognizes this common configuration of four hydrophobic residues in the NES to form a complex. Identification of a common NES receptor should be the next step.
